Repligen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Repligen and other ETFs, options, and stocks.

About RGEN

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. 

CEO
Olivier Dominique Loeillot
CEOOlivier Dominique Loeillot
Employees
2,000
Employees2,000
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
1981
Founded1981
Employees
2,000
Employees2,000

RGEN Key Statistics

Market cap
7.21B
Market cap7.21B
Price-Earnings ratio
138.81
Price-Earnings ratio138.81
Dividend yield
Dividend yield
Average volume
934.49K
Average volume934.49K
High today
$128.14
High today$128.14
Low today
$118.06
Low today$118.06
Open price
$119.28
Open price$119.28
Volume
1.10M
Volume1.10M
52 Week high
$175.77
52 Week high$175.77
52 Week low
$102.97
52 Week low$102.97

Stock Snapshot

The current Repligen(RGEN) stock price is $127.89, with a market capitalization of 7.21B. The stock trades at a price-to-earnings (P/E) ratio of 138.81.

During the trading session on 2026-03-09, Repligen(RGEN) shares reached a daily high of $128.14 and a low of $118.06. At a current price of $127.89, the stock is +8.3% higher than the low and still -0.2% under the high.

Trading volume for Repligen(RGEN) stock has reached 1.1M, versus its average volume of 934.49K.

Over the past 52 weeks, Repligen(RGEN) stock has traded between a high of $175.77 and a low of $102.97.

Over the past 52 weeks, Repligen(RGEN) stock has traded between a high of $175.77 and a low of $102.97.

RGEN News

Simply Wall St 1d
Reassessing Repligen Valuation After Healthcare Jobs Shock And Margin Concerns

Repligen (RGEN) has been under pressure after a weaker February jobs report hit healthcare stocks, even as the company recently reported quarterly and full year...

Reassessing Repligen Valuation After Healthcare Jobs Shock And Margin Concerns
Simply Wall St 3d
Are Repligen's Stronger Earnings Masking Deeper Pressure On Its High-Margin Growth Story?

Repligen Corporation recently reported its fourth-quarter and full-year 2025 results, with revenue rising to US$197.91 million for the quarter and US$738.26 mil...

Are Repligen's Stronger Earnings Masking Deeper Pressure On Its High-Margin Growth Story?

Analyst ratings

82%

of 22 ratings
Buy
81.8%
Hold
18.2%
Sell
0%

People also own

Based on the portfolios of people who own RGEN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.